Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Altea Therapeutics for $391,878.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44DK057381-02 | Phase II | 391,878 | ||||||||
A SBIR Phase II contract was awarded to Altea Therapeutics for $781,633.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM066609-02A1 | Phase II | 781,633 | ||||||||
A SBIR Phase I contract was awarded to Altea Therapeutics for $100,660.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM074342-01 | Phase I | 100,660 | ||||||||
A SBIR Phase I contract was awarded to Altea Therapeutics for $105,650.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM066609-01 | Phase I | 105,650 | ||||||||
A SBIR Phase I contract was awarded to Altea Therapeutics from the U.S. Department of Health & Human Services. | SBIR | 2R44DK057381-02 | Phase I | 0 | ||||||||
A SBIR Phase I contract was awarded to Altea Therapeutics for $97,910.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 97,910 | |||||||||
A SBIR Phase I contract was awarded to Altea Therapeutics for $99,442.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 99,442 |